222 related articles for article (PubMed ID: 10903019)
41. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
Green WS; Toy P; Bozic KJ
J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
[TBL] [Abstract][Full Text] [Related]
42. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
[TBL] [Abstract][Full Text] [Related]
43. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty.
Gonzalez-Porras JR; Colado E; Conde MP; Lopez T; Nieto MJ; Corral M
Transfus Med; 2009 Feb; 19(1):35-42. PubMed ID: 19302453
[TBL] [Abstract][Full Text] [Related]
44. Autologous blood transfusion with recombinant human erythropoietin in heart operations.
Watanabe Y; Fuse K; Konishi T; Kobayasi T; Takazawa K; Konishi H; Shibata Y
Ann Thorac Surg; 1991 May; 51(5):767-72. PubMed ID: 2025081
[TBL] [Abstract][Full Text] [Related]
45. Quality of the blood sampled from surgical drainage after total hip arthroplasty.
Tripković B; Buković D; Sakić K; Sakić S; Buković N; Radaković B
Coll Antropol; 2008 Mar; 32(1):153-60. PubMed ID: 18494201
[TBL] [Abstract][Full Text] [Related]
46. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
47. Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial.
Moonen AF; Thomassen BJ; Knoors NT; van Os JJ; Verburg AD; Pilot P
J Bone Joint Surg Br; 2008 Aug; 90(8):1079-83. PubMed ID: 18669967
[TBL] [Abstract][Full Text] [Related]
48. Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.
Ayash LJ; Elias A; Hunt M; Demetri G; Wheeler C; Tepler I; Schwartz G; Mazanet R; Reich E; McCauley M
Br J Haematol; 1994 May; 87(1):153-61. PubMed ID: 7947240
[TBL] [Abstract][Full Text] [Related]
49. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.
Feagan BG; Wong CJ; Kirkley A; Johnston DW; Smith FC; Whitsitt P; Wheeler SL; Lau CY
Ann Intern Med; 2000 Dec; 133(11):845-54. PubMed ID: 11103054
[TBL] [Abstract][Full Text] [Related]
50. [Effectiveness of autologous blood replacement in rheumatoid arthritis surgery--a report of 10 years experience].
Quoss A; Paululat S
Anaesthesiol Reanim; 1997; 22(5):125-9. PubMed ID: 9445534
[TBL] [Abstract][Full Text] [Related]
51. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
[TBL] [Abstract][Full Text] [Related]
52. [Recombinant human erythropoietin (KRN5702) therapy for autologous blood transfusion in patients with rheumatoid arthritis undergoing joint replacement surgery--a multicenter phase II clinical trial].
Saikawa I; Sugioka Y; Hotokebuchi T; Tsutsui H; Inaba S; Takagishi K; Iwata H; Ogawa R; Kondo M; Ogata K
Ryumachi; 1994 Jun; 34(3):583-93. PubMed ID: 8052924
[TBL] [Abstract][Full Text] [Related]
53. Blood salvage in total hip and knee arthroplasty in a community hospital: a retrospective study.
Jain R; Jain S
J Orthop Surg (Hong Kong); 2005 Apr; 13(1):19-26. PubMed ID: 15872396
[TBL] [Abstract][Full Text] [Related]
54. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin.
Biesma DH; Marx JJ; Kraaijenhagen RJ; Franke W; Messinger D; van de Wiel A
Lancet; 1994 Aug; 344(8919):367-70. PubMed ID: 7914307
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of autotransfusion in spine surgery: comparison of autotransfusion alone and with hemodilution and apheresis.
Blais RE; Hadjipavlou AG; Shulman G
Spine (Phila Pa 1976); 1996 Dec; 21(23):2795-800. PubMed ID: 8979328
[TBL] [Abstract][Full Text] [Related]
56. The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty: the effect on subsequent transfusion rates.
Couvret C; Tricoche S; Baud A; Dabo B; Buchet S; Palud M; Fusciardi J
Anesth Analg; 2002 Apr; 94(4):815-23, table of contents. PubMed ID: 11916778
[TBL] [Abstract][Full Text] [Related]
57. Erythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery.
Sonzogni V; Crupi G; Poma R; Annechino F; Ferri F; Filisetti P; Bellavita P
Br J Anaesth; 2001 Sep; 87(3):429-34. PubMed ID: 11517127
[TBL] [Abstract][Full Text] [Related]
58. The use of autologous blood to improve exercise capacity after total hip arthroplasty: a preliminary report.
Pilot P; Bols EM; Verburg AD; Bell CA; Moonen AF; van Os JJ; Koolen JJ; Geesink RG; Kuipers H
Transfusion; 2006 Sep; 46(9):1484-90. PubMed ID: 16965573
[TBL] [Abstract][Full Text] [Related]
59. Transfusion options in total joint arthroplasty.
Keating EM; Ritter MA
J Arthroplasty; 2002 Jun; 17(4 Suppl 1):125-8. PubMed ID: 12068422
[TBL] [Abstract][Full Text] [Related]
60. Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery.
Copley LA; Richards BS; Safavi FZ; Newton PO
Spine (Phila Pa 1976); 1999 Feb; 24(3):219-22; discussion 223-4. PubMed ID: 10025016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
